PMID- 35180101 OWN - NLM STAT- MEDLINE DCOM- 20230124 LR - 20230201 IS - 1878-3619 (Electronic) IS - 0959-2989 (Linking) VI - 34 IP - 1 DP - 2023 TI - Immunological characteristics of human umbilical cord mesenchymal stem cells after hepatogenic differentiation. PG - 1-11 LID - 10.3233/BME-211331 [doi] AB - BACKGROUND: Acute liver failure is one of the most intractable clinical problems. The use of bioartificial livers may solve donor shortage problems. Human umbilical cord mesenchymal stem cells (hUCMSCs) are an excellent seed cell choice for artificial livers because they change their characteristics to resemble hepatocyte-like cells (HLCs) following artificial liver transplantation. OBJECTIVE: This study aimed to determine whether the immunological characteristics of hUCMSCs are changed after being transformed into hepatocyte-like cells. METHODS: HUCMSCs were isolated by the adherent method. The following hUCMSC surface markers were detected using flow cytometry: CD45, CD90, CD105, CD34, and octamer-binding transcription factor 4 (OCT-4). Functional detection of adipogenic differentiation was performed. The hUCMSCs were cultured in complete medium (control group) or induction medium (induction group), and flow cytometry was used to detect cell surface markers. Peritoneal lavage fluid was collected after intraperitoneal injection of 1 x 106 cells/mouse over 40 minutes. The leukocyte count, labeled CD45, CD3, CD4 and CD8 antibodies, and flow detection of T lymphocyte subsets were determined using the peritoneal lavage fluid. RESULTS: Using phenotypic and functional identification, hUCMSCs were successfully isolated using a two-step induction method. The surface markers of the hUCMSCs cells changed after HLC induction. In vivo immune results showed that hUCMSCs and HLsC induced leukocyte production. CONCLUSION: Hepatic induction of hUCMSCs changes their cell surface markers. Both HLCs and hUCMSCs cause leukocytosis in vivo, but the immune response induced by HLCs is slightly stronger. FAU - Yin, Yanfeng AU - Yin Y AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Hu, Zongqiang AU - Hu Z AD - Department of Hepatobiliary Surgery, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Guan, Zheng AU - Guan Z AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Lv, Sha AU - Lv S AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Wang, Yiyin AU - Wang Y AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Su, Wenjun AU - Su W AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Yan, Chuntao AU - Yan C AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Wang, Yiting AU - Wang Y AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Ma, Li AU - Ma L AD - Biomedical Research Center, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Jiang, Jie AU - Jiang J AD - Department of Hepatobiliary Surgery, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Feng, Shiming AU - Feng S AD - Department of Hepatobiliary Surgery, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. FAU - Li, Li AU - Li L AD - Department of Hepatobiliary Surgery, The First Hospital of Kunming (the Affiliated Calmette Hospital of Kunming Medical University), Kunming, China. LA - eng PT - Journal Article PL - Netherlands TA - Biomed Mater Eng JT - Bio-medical materials and engineering JID - 9104021 SB - IM MH - Humans MH - Animals MH - Mice MH - Cell Differentiation MH - Liver MH - Hepatocytes MH - *Mesenchymal Stem Cells MH - Umbilical Cord MH - *Mesenchymal Stem Cell Transplantation/methods OTO - NOTNLM OT - differentiation OT - hUCMSC OT - hepatocyte-like cell OT - immunogenicity OT - liver EDAT- 2022/02/19 06:00 MHDA- 2023/01/25 06:00 CRDT- 2022/02/18 17:08 PHST- 2022/02/19 06:00 [pubmed] PHST- 2023/01/25 06:00 [medline] PHST- 2022/02/18 17:08 [entrez] AID - BME211331 [pii] AID - 10.3233/BME-211331 [doi] PST - ppublish SO - Biomed Mater Eng. 2023;34(1):1-11. doi: 10.3233/BME-211331.